Bitcoin Slips to 74500 Faces Potential Weekly Decline Amid Geopolitical Tensions Restaurants Experiment With PayWhatYouWant Pricing as DiningOut Declines Judge Dismisses Criminal Case Against Wrongfully Deported Maryland Man Potential Legal and Policy Implications French Presidential Race Former PM Philippe Emerges as Potential Centrist Challenger to Populist Contenders Inflation Rate Projected to Hit 6 in Second Quarter Top Economic Forecasters Say Apple CoFounder Steve Wozniak Reveals He Founded Apple After HP Rejections Not for Profit With a 50 Paycheck CGBD Q1 2026 Earnings Narrow EPS Miss Weighs on Investor Sentiment as Portfolio Remains Resilient LendingTree TREE Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty ICON Q4 2025 Earnings EPS Misses Estimates as Loss Widens Shares Rise 075 Telus Q1 2026 Earnings EPS Beats Expectations Amid Cautious Growth Outlook SXT Q1 2026 Earnings EPS Surges Past Estimates by 22 Shares Edge Higher UHT Q1 2026 Earnings EPS Beats in Absence of Consensus Shares Edge Higher BRC Inc BRCC Edges Higher as Investors Eye Key Resistance Levels Scully Royalty Ltd SRL Stalls at 612 Trading in a Tight Range Near Support CAAS Shows Modest Decline Amid Consolidation Range Support at 44 Resistance at 486 MGP Ingredients Surges 27 Key Levels and Market Dynamics Caribou Biosciences CRBU Holds Steady at 231 as Key Technical Levels Come Into Focus Corporate Giants Double Down on Prediction Market Investments Despite Regulatory Uncertainty Rising Bankruptcy Risks in Singapore Overspending and Business Failures Drive Financial Distress UK Startup BioOrbit Sends DrugCrystallisation Technology to Space for Potential Cancer Treatment Breakthrough Britains Energy Shock MiniMeasures May Not Be Sufficient Guardian Editorial Warns Micron Technologys Surge to 1 Trillion Market Cap Lifts US Stocks to Record Highs Trump Refiles 10 Billion Lawsuit Against The Wall Street Journal Stellantis Refocuses on Jeep Ram Peugeot and Fiat in Major Strategic Overhaul Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Surpasses Estimates by 448 Amid Slight Stock Decline Fennec Pharmaceuticals FENC Holds Steady Near Support as Investors Assess Outlook